News

CATS1 Phase I/II trial intends to investigate the tolerability and efficacy of Ovasave, a type 1 regulatory T cell based immunotherapy, in patients with severe chronic active Crohn’s

Medical Office Online is a 2011-2012 ONC-ATCB certified integrated solution which meets the requirements for meaningful use and is therefore eligible for funding through the federal government’s ARRA

Axitinib is an oral and selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2 and 3, receptors that can influence tumor growth, vascular angiogenesis and progression

Aquaprin, a liquid derivative of aspirin, is the US Food and Drug Administration approved over-the-counter (OTC) liquid pain reliever. PharmStar Pharmaceuticals claims the product is designed to dissolve

TCGRx claims MedPickRx not only reduces oral solid formulary prescription fill time upto 40%, but also eliminates shelving space with its high density storage capacity. The saved space

FSH-GEX is a follicle-stimulating hormone for in-vitro fertilisation and the treatment of anovulatory infertility. FSH-GEX is based on GlycoExpress, Glycotope´s development and production platform of glycoengineered human cell

PFC is a pan-European contract research provider focused on drug and medical device development services and regulatory consulting. The combination of PFC and Clinipace Worldwide is expected to

The trial is being conducted under a Special Protocol Assessment (SPA) granted by the US Food and Drug Administration (FDA), which ensures that the agreed clinical trial design

In the trial, the company will investigate the safety and urate-lowering activity of arhalofenate 400mg and 600mg in around 60 patients with hyperuricemia. Arhalofenate’s eight Phase 1 and